Click for best price
Dermatological OTC Drugs Market Size, Share 2022
This report contains market size and forecasts of Dermatological OTC Drugs in Global, including the following market information:
The global Dermatological OTC Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Acne Medications Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Dermatological OTC Drugs include Perrigo Company plc, Bausch Health Companies Inc., Dr. Reddy's Laboratories, Johnson and Johnson, Bayer AG, GlaxoSmithKline plc., Viatris Inc, LEO Pharma A/S and Acella Pharmaceuticals, LLC, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Dermatological OTC Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dermatological OTC Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Dermatological OTC Drugs Market Segment Percentages, by Type, 2021 (%)
- Acne Medications
- Dermatitis Drugs
- Fungal Infection Drugs
Global Dermatological OTC Drugs Market, by Distribution Channel, 2017-2022, 2023-2028 ($ millions)
Global Dermatological OTC Drugs Market Segment Percentages, by Distribution Channel, 2021 (%)
- Online Distribution
- Offline Distribution
Global Dermatological OTC Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Dermatological OTC Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Dermatological OTC Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Dermatological OTC Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Perrigo Company plc
- Bausch Health Companies Inc.
- Dr. Reddy's Laboratories
- Johnson and Johnson
- Bayer AG
- GlaxoSmithKline plc.
- Viatris Inc
- LEO Pharma A/S
- Acella Pharmaceuticals, LLC
- Teva Pharmaceutical Industries Ltd.
- Galderma
| Report Attributes |
Report Details |
| Report Title |
Dermatological OTC Drugs Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
60 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Dermatological OTC Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Distribution Channel
1.3 Global Dermatological OTC Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Dermatological OTC Drugs Overall Market Size
2.1 Global Dermatological OTC Drugs Market Size: 2021 VS 2028
2.2 Global Dermatological OTC Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Dermatological OTC Drugs Players in Global Market
3.2 Top Global Dermatological OTC Drugs Companies Ranked by Revenue
3.3 Global Dermatological OTC Drugs Revenue by Companies
3.4 Top 3 and Top 5 Dermatological OTC Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Dermatological OTC Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Dermatological OTC Drugs Players in Global Market
3.6.1 List of Global Tier 1 Dermatological OTC Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Dermatological OTC Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Dermatological OTC Drugs Market Size Markets, 2021 & 2028
4.1.2 Acne Medications
4.1.3 Dermatitis Drugs
4.1.4 Fungal Infection Drugs
4.2 By Type - Global Dermatological OTC Drugs Revenue & Forecasts
4.2.1 By Type - Global Dermatological OTC Drugs Revenue, 2017-2022
4.2.2 By Type - Global Dermatological OTC Drugs Revenue, 2023-2028
4.2.3 By Type - Global Dermatological OTC Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Dermatological OTC Drugs Market Size, 2021 & 2028
5.1.2 Online Distribution
5.1.3 Offline Distribution
5.2 By Distribution Channel - Global Dermatological OTC Drugs Revenue & Forecasts
5.2.1 By Distribution Channel - Global Dermatological OTC Drugs Revenue, 2017-2022
5.2.2 By Distribution Channel - Global Dermatological OTC Drugs Revenue, 2023-2028
5.2.3 By Distribution Channel - Global Dermatological OTC Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Dermatological OTC Drugs Market Size, 2021 & 2028
6.2 By Region - Global Dermatological OTC Drugs Revenue & Forecasts
6.2.1 By Region - Global Dermatological OTC Drugs Revenue, 2017-2022
6.2.2 By Region - Global Dermatological OTC Drugs Revenue, 2023-2028
6.2.3 By Region - Global Dermatological OTC Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Dermatological OTC Drugs Revenue, 2017-2028
6.3.2 US Dermatological OTC Drugs Market Size, 2017-2028
6.3.3 Canada Dermatological OTC Drugs Market Size, 2017-2028
6.3.4 Mexico Dermatological OTC Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Dermatological OTC Drugs Revenue, 2017-2028
6.4.2 Germany Dermatological OTC Drugs Market Size, 2017-2028
6.4.3 France Dermatological OTC Drugs Market Size, 2017-2028
6.4.4 U.K. Dermatological OTC Drugs Market Size, 2017-2028
6.4.5 Italy Dermatological OTC Drugs Market Size, 2017-2028
6.4.6 Russia Dermatological OTC Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Dermatological OTC Drugs Market Size, 2017-2028
6.4.8 Benelux Dermatological OTC Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Dermatological OTC Drugs Revenue, 2017-2028
6.5.2 China Dermatological OTC Drugs Market Size, 2017-2028
6.5.3 Japan Dermatological OTC Drugs Market Size, 2017-2028
6.5.4 South Korea Dermatological OTC Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Dermatological OTC Drugs Market Size, 2017-2028
6.5.6 India Dermatological OTC Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Dermatological OTC Drugs Revenue, 2017-2028
6.6.2 Brazil Dermatological OTC Drugs Market Size, 2017-2028
6.6.3 Argentina Dermatological OTC Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Dermatological OTC Drugs Revenue, 2017-2028
6.7.2 Turkey Dermatological OTC Drugs Market Size, 2017-2028
6.7.3 Israel Dermatological OTC Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Dermatological OTC Drugs Market Size, 2017-2028
6.7.5 UAE Dermatological OTC Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Perrigo Company plc
7.1.1 Perrigo Company plc Corporate Summary
7.1.2 Perrigo Company plc Business Overview
7.1.3 Perrigo Company plc Dermatological OTC Drugs Major Product Offerings
7.1.4 Perrigo Company plc Dermatological OTC Drugs Revenue in Global Market (2017-2022)
7.1.5 Perrigo Company plc Key News
7.2 Bausch Health Companies Inc.
7.2.1 Bausch Health Companies Inc. Corporate Summary
7.2.2 Bausch Health Companies Inc. Business Overview
7.2.3 Bausch Health Companies Inc. Dermatological OTC Drugs Major Product Offerings
7.2.4 Bausch Health Companies Inc. Dermatological OTC Drugs Revenue in Global Market (2017-2022)
7.2.5 Bausch Health Companies Inc. Key News
7.3 Dr. Reddy's Laboratories
7.3.1 Dr. Reddy's Laboratories Corporate Summary
7.3.2 Dr. Reddy's Laboratories Business Overview
7.3.3 Dr. Reddy's Laboratories Dermatological OTC Drugs Major Product Offerings
7.3.4 Dr. Reddy's Laboratories Dermatological OTC Drugs Revenue in Global Market (2017-2022)
7.3.5 Dr. Reddy's Laboratories Key News
7.4 Johnson and Johnson
7.4.1 Johnson and Johnson Corporate Summary
7.4.2 Johnson and Johnson Business Overview
7.4.3 Johnson and Johnson Dermatological OTC Drugs Major Product Offerings
7.4.4 Johnson and Johnson Dermatological OTC Drugs Revenue in Global Market (2017-2022)
7.4.5 Johnson and Johnson Key News
7.5 Bayer AG
7.5.1 Bayer AG Corporate Summary
7.5.2 Bayer AG Business Overview
7.5.3 Bayer AG Dermatological OTC Drugs Major Product Offerings
7.5.4 Bayer AG Dermatological OTC Drugs Revenue in Global Market (2017-2022)
7.5.5 Bayer AG Key News
7.6 GlaxoSmithKline plc.
7.6.1 GlaxoSmithKline plc. Corporate Summary
7.6.2 GlaxoSmithKline plc. Business Overview
7.6.3 GlaxoSmithKline plc. Dermatological OTC Drugs Major Product Offerings
7.6.4 GlaxoSmithKline plc. Dermatological OTC Drugs Revenue in Global Market (2017-2022)
7.6.5 GlaxoSmithKline plc. Key News
7.7 Viatris Inc
7.7.1 Viatris Inc Corporate Summary
7.7.2 Viatris Inc Business Overview
7.7.3 Viatris Inc Dermatological OTC Drugs Major Product Offerings
7.7.4 Viatris Inc Dermatological OTC Drugs Revenue in Global Market (2017-2022)
7.7.5 Viatris Inc Key News
7.8 LEO Pharma A/S
7.8.1 LEO Pharma A/S Corporate Summary
7.8.2 LEO Pharma A/S Business Overview
7.8.3 LEO Pharma A/S Dermatological OTC Drugs Major Product Offerings
7.8.4 LEO Pharma A/S Dermatological OTC Drugs Revenue in Global Market (2017-2022)
7.8.5 LEO Pharma A/S Key News
7.9 Acella Pharmaceuticals, LLC
7.9.1 Acella Pharmaceuticals, LLC Corporate Summary
7.9.2 Acella Pharmaceuticals, LLC Business Overview
7.9.3 Acella Pharmaceuticals, LLC Dermatological OTC Drugs Major Product Offerings
7.9.4 Acella Pharmaceuticals, LLC Dermatological OTC Drugs Revenue in Global Market (2017-2022)
7.9.5 Acella Pharmaceuticals, LLC Key News
7.10 Teva Pharmaceutical Industries Ltd.
7.10.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
7.10.2 Teva Pharmaceutical Industries Ltd. Business Overview
7.10.3 Teva Pharmaceutical Industries Ltd. Dermatological OTC Drugs Major Product Offerings
7.10.4 Teva Pharmaceutical Industries Ltd. Dermatological OTC Drugs Revenue in Global Market (2017-2022)
7.10.5 Teva Pharmaceutical Industries Ltd. Key News
7.11 Galderma
7.11.1 Galderma Corporate Summary
7.11.2 Galderma Business Overview
7.11.3 Galderma Dermatological OTC Drugs Major Product Offerings
7.11.4 Galderma Dermatological OTC Drugs Revenue in Global Market (2017-2022)
7.11.5 Galderma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Dermatological OTC Drugs Market Opportunities & Trends in Global Market
Table 2. Dermatological OTC Drugs Market Drivers in Global Market
Table 3. Dermatological OTC Drugs Market Restraints in Global Market
Table 4. Key Players of Dermatological OTC Drugs in Global Market
Table 5. Top Dermatological OTC Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Dermatological OTC Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Dermatological OTC Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Dermatological OTC Drugs Product Type
Table 9. List of Global Tier 1 Dermatological OTC Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dermatological OTC Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Dermatological OTC Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Dermatological OTC Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Dermatological OTC Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Distribution Channel ? Global Dermatological OTC Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Distribution Channel - Dermatological OTC Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Distribution Channel - Dermatological OTC Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Dermatological OTC Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Dermatological OTC Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Dermatological OTC Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Dermatological OTC Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Dermatological OTC Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Dermatological OTC Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Dermatological OTC Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Dermatological OTC Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Dermatological OTC Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Dermatological OTC Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Dermatological OTC Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Dermatological OTC Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Dermatological OTC Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Perrigo Company plc Corporate Summary
Table 31. Perrigo Company plc Dermatological OTC Drugs Product Offerings
Table 32. Perrigo Company plc Dermatological OTC Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Bausch Health Companies Inc. Corporate Summary
Table 34. Bausch Health Companies Inc. Dermatological OTC Drugs Product Offerings
Table 35. Bausch Health Companies Inc. Dermatological OTC Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Dr. Reddy's Laboratories Corporate Summary
Table 37. Dr. Reddy's Laboratories Dermatological OTC Drugs Product Offerings
Table 38. Dr. Reddy's Laboratories Dermatological OTC Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Johnson and Johnson Corporate Summary
Table 40. Johnson and Johnson Dermatological OTC Drugs Product Offerings
Table 41. Johnson and Johnson Dermatological OTC Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Bayer AG Corporate Summary
Table 43. Bayer AG Dermatological OTC Drugs Product Offerings
Table 44. Bayer AG Dermatological OTC Drugs Revenue (US$, Mn), (2017-2022)
Table 45. GlaxoSmithKline plc. Corporate Summary
Table 46. GlaxoSmithKline plc. Dermatological OTC Drugs Product Offerings
Table 47. GlaxoSmithKline plc. Dermatological OTC Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Viatris Inc Corporate Summary
Table 49. Viatris Inc Dermatological OTC Drugs Product Offerings
Table 50. Viatris Inc Dermatological OTC Drugs Revenue (US$, Mn), (2017-2022)
Table 51. LEO Pharma A/S Corporate Summary
Table 52. LEO Pharma A/S Dermatological OTC Drugs Product Offerings
Table 53. LEO Pharma A/S Dermatological OTC Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Acella Pharmaceuticals, LLC Corporate Summary
Table 55. Acella Pharmaceuticals, LLC Dermatological OTC Drugs Product Offerings
Table 56. Acella Pharmaceuticals, LLC Dermatological OTC Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Teva Pharmaceutical Industries Ltd. Corporate Summary
Table 58. Teva Pharmaceutical Industries Ltd. Dermatological OTC Drugs Product Offerings
Table 59. Teva Pharmaceutical Industries Ltd. Dermatological OTC Drugs Revenue (US$, Mn), (2017-2022)
Table 60. Galderma Corporate Summary
Table 61. Galderma Dermatological OTC Drugs Product Offerings
Table 62. Galderma Dermatological OTC Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Dermatological OTC Drugs Segment by Type in 2021
Figure 2. Dermatological OTC Drugs Segment by Distribution Channel in 2021
Figure 3. Global Dermatological OTC Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Dermatological OTC Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Dermatological OTC Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Dermatological OTC Drugs Revenue in 2021
Figure 8. By Type - Global Dermatological OTC Drugs Revenue Market Share, 2017-2028
Figure 9. By Distribution Channel - Global Dermatological OTC Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Dermatological OTC Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Dermatological OTC Drugs Revenue Market Share, 2017-2028
Figure 12. US Dermatological OTC Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Dermatological OTC Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Dermatological OTC Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Dermatological OTC Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Dermatological OTC Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Dermatological OTC Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Dermatological OTC Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Dermatological OTC Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Dermatological OTC Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Dermatological OTC Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Dermatological OTC Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Dermatological OTC Drugs Revenue Market Share, 2017-2028
Figure 24. China Dermatological OTC Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Dermatological OTC Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Dermatological OTC Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Dermatological OTC Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Dermatological OTC Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Dermatological OTC Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Dermatological OTC Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Dermatological OTC Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Dermatological OTC Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Dermatological OTC Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Dermatological OTC Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Dermatological OTC Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Dermatological OTC Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Perrigo Company plc Dermatological OTC Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bausch Health Companies Inc. Dermatological OTC Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Dr. Reddy's Laboratories Dermatological OTC Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Johnson and Johnson Dermatological OTC Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bayer AG Dermatological OTC Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. GlaxoSmithKline plc. Dermatological OTC Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Viatris Inc Dermatological OTC Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. LEO Pharma A/S Dermatological OTC Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Acella Pharmaceuticals, LLC Dermatological OTC Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Teva Pharmaceutical Industries Ltd. Dermatological OTC Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Galderma Dermatological OTC Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
